Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

8.7%

2 terminated/withdrawn out of 23 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

39%

9 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed trials have results

Key Signals

4 recruiting1 with results

Enrollment Performance

Analytics

N/A

9(42.9%)

Phase 3

8(38.1%)

Phase 2

2(9.5%)

Early Phase 1

1(4.8%)

Phase 4

1(4.8%)

21Total

N/A(9)

Phase 3(8)

Phase 2(2)

Early Phase 1(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (23)

Showing 20 of 23 trials

NCT06585969Phase 3Withdrawn

A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast Cancer

Role: lead

NCT07007169Phase 2Recruiting

Mediterranean Diet and Inequality in Early Breast Cancer

Role: collaborator

NCT04335669Phase 3Active Not Recruiting

NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

Role: collaborator

NCT03730922Not ApplicableRecruiting

Delayed-immediate Versus Delayed Breast Reconstruction in Breast Cancer Patients With Mastectomy and Radiation Therapy

Role: lead

NCT03562832Phase 2Completed

Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the 2X-121 DRP

Role: collaborator

NCT06549920Not ApplicableActive Not Recruiting

Danish Breast Cancer Group Internal Mammary Node Study

Role: lead

NCT04177628Not ApplicableCompleted

Shared Decision Making With Breast Cancer Patients

Role: collaborator

NCT00909818Not ApplicableUnknown

Hypofractionated Versus Standard Fractionated Whole Breast Irradiation to Node-negative Breast Cancer Patients

Role: lead

NCT02384733Not ApplicableActive Not Recruiting

Hypofractionated Loco-regional Adjuvant Radiation Therapy of Breast Cancer Combined With a Simultaneous Integrated Boost

Role: lead

NCT04291378Not ApplicableRecruiting

The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast Cancer

Role: lead

NCT03646955Not ApplicableRecruiting

Partial Breast Versus no Irradiation for Women With Early Breast Cancer

Role: lead

NCT00892814Not ApplicableActive Not Recruiting

Partial Breast Versus Whole Breast Irradiation in Elderly Women Operated on for Early Breast Cancer

Role: lead

NCT00908531Phase 3Terminated

Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer

Role: lead

NCT03888677Phase 3Completed

Dose-adjusted Adjuvant FEC Compared to Standard FEC for Breast Cancer

Role: collaborator

NCT00689156Phase 3Completed

Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer

Role: lead

NCT00004205Phase 3Completed

Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer

Role: collaborator

NCT00171704Phase 3Completed

A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer

Role: collaborator

NCT01523132Completed

Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms

Role: collaborator

NCT02444026Not ApplicableUnknown

Feasibility and Efficacy of Internet-delivered CBT for Insomnia in a National Cohort of Danish Breast Cancer Survivors

Role: collaborator

NCT00413491Phase 4Unknown

National Screening in Denmark With MR Versus Mammography and Ultrasound of Women With BRCA1 or BRCA2 Mutations

Role: lead